ID   I-10/DDPi
AC   CVCL_HF53
DR   Wikidata; Q54897069
RX   PubMed=26714911;
CC   Selected for resistance to: ChEBI; CHEBI_27899; Cisplatin (CDDP).
CC   Derived from site: In situ; Testis; UBERON=UBERON_0000473.
CC   Cell type: Leydig cell; CL=CL_0000178.
CC   Breed/subspecies: BALB/cJ.
DI   NCIt; C134947; Mouse Leydig cell tumor
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_3527 ! I-10
SX   Male
CA   Cancer cell line
DT   Created: 01-12-16; Last updated: 19-12-24; Version: 7
//
RX   PubMed=26714911; DOI=10.3969/j.issn.1673-4254.2015.12.18;
RA   Li B.-B., Dong S.-Y., Fan Z.-B., Wu X.-X., Wu J.-F., Tong X.-H.;
RT   "Comparison of cisplatin-resistant testicular cancer cell lines
RT   established by two methods.";
RL   Nan Fang Yi Ke Da Xue Xue Bao 35:1755-1759(2015).
//